Yael Margolin - President & CEO
Dr. Margolin is the president and CEO of Gamida Cell. Prior to joining the company, Dr. Margolin served as vice president of Denali Ventures LLC, where she specialized in investments in pharmaceutical and biotechnology companies. Dr. Margolin also worked at Teva Pharmaceuticals, where she was responsible for new product initiatives, evaluation of investment opportunities for the R&D division, and multiple drug development programs. Dr. Margolin holds a Ph.D. in Biology from the Weizmann Institute of Science and was a post-doctoral associate at the Yale University School of Medicine.
Tony Peled - Chief Scientific Officer and Vice President of Research & Development
Tony Peled is the co-founder of the company and the researcher credited with the discoveries that have led to Gamida Cell’s key patents, and is leading the development of Gamida Cell's various novel technologies and pipeline of products. Prior to founding Gamida Cell, she was a scientist at the Hematology Department, Hadassah University Hospital, Jerusalem, Israel and has 15 years of experience in hematopoiesis and stem cell research.
Naftali Brikashvili - CFO
Naftali Brikashvili has more than 15 years of experience in all aspects of accounting and finance. He is responsible for all the financial aspects of Gamida Cell. Prior to joining the company in April 2000, Mr. Brikashvili served as the finance manager at Donna Engineering Construction and Mertens Hoffman Software & Logistics. He has a B.A. in accounting & economics from the Hebrew University, Jerusalem and an LLM degree from Bar Ilan University. Mr. Brikashvili earned his CPA license in 1996.
David Snyder - Vice President, Clinical Development and Regulatory Affairs
Dr. Snyder has worked on the senior management teams of international pharmaceutical and biotechnology companies in the US and in Israel. Dr. Snyder is highly experienced in the design and management of clinical strategies and protocols as well as the supervision of sponsor interactions with the regulatory agencies in these areas. His focus for nearly the last ten years has been advising and directing high-level communications with opinion leaders, consultants and regulatory agencies in the field of cellular therapies. Dr. Snyder earned a Ph.D. in medical biochemistry from the Hebrew University in Jerusalem and performed his post-doctoral work in neurobiology at Duke University.
Dorit Harati - Vice President, Quality Assurance
Dorit Harati has 16 years of experience in the pharmaceutical and biotechnology industries. Prior to joining Gamida Cell, Ms. Harati served as the director of the quality control laboratories at Perio Products Ltd., a pharmaceutical company specializing in manufacturing innovative drugs. While at Perio Products she implemented quality systems in accordance with FDA requirements and European regulations. Her primary expertise is in building and developing quality from the first steps of product development to marketing.
Michal Austin - 1969-2012